Table 3. Summary of TAPPS model development.
Model | Marker | HR | 95%CI | P-value | Coefficient |
---|---|---|---|---|---|
Full (Individual Markers) |
TEM1 Stroma | 0.41 | 0.24-0.69 | 0.001 | −0.89 |
TEM1 Tumor Vessel | 3.27 | 1.35-7.95 | 0.009 | 1.19 | |
HIF2α Stromal Vessel | 0.47 | 0.25-0.88 | 0.02 | −0.76 | |
Collagen IV Tumor | 1.86 | 1.08-3.21 | 0.03 | 0.62 | |
FN Stroma | 2.29 | 1.23-3.21 | 0.009 | 0.83 | |
Full (TAPPS Score) |
TAPPS (Training)n=330 | 1.76 | 1.44-2.15 | <0.001 | NA |
TAPPS (Validation)n=164 | 1.38 | 1.02-1.88 | 0.04 | NA | |
TAPPS (w/Clinical)n=494 | 1.66 | 1.37-2.03 | <0.001 | NA | |
TAPPS (Stage II)n=126 | 1.75 | 1.22-2.52 | 0.002 | NA | |
TAPPS (Stage III/IV)n=235 | 1.40 | 1.14-1.73 | 0.001 | NA | |
Minimal (Individual Markers) |
TEM-1 Stroma | 0.58 | 0.36-0.93 | 0.03 | −0.55 |
Collagen IV Tumor | 1.90 | 1.12-3.25 | 0.02 | 0.64 | |
FN Stroma | 2.18 | 1.18-4.05 | 0.01 | 0.78 | |
Minimal (TAPPS Score) |
mTAPPS (Training)n=330 | 2.72 | 1.82-4.08 | <0.001 | NA |
mTAPPS (Validation)n=164 | 2.66 | 1.26-5.62 | 0.01 | NA | |
mTAPPS (w/Clinical)n=494 | 2.37 | 1.48-3.81 | <0.001 | NA | |
mTAPPS (Stage II)n=126 | 3.99 | 1.71-9.29 | 0.001 | NA | |
mTAPPS (Stage III/IV)n=234 | 1.94 | 1.27-2.98 | 0.002 | NA |